Email Updates

You are here

AVAC in the News

  • One of the biggest HIV vaccine trials in the world, the HVTN 702 study, was stopped late on Monday because the vaccine had not been proven effective in preventing HIV. This is according to the United States National Institute of Allergy and Infectious Diseases (NIAID), who are one of the funders of the clinical trial.

    February 4, 2020
    Health-E News
  • The HIV vaccine that had moved furthest along in human testing does not work, and the $104 million trial in South Africa evaluating it has been stopped early.

    February 3, 2020
    Science
  • A clinical trial testing a promising HIV vaccine in more than 5,000 people in South Africa has been halted because it failed to show a benefit, US health officials said on Monday.

    February 3, 2020
    Reuters
  • In another blow to the decades-long quest for an HIV vaccine, researchers are pulling the plug on the largest ongoing clinical trial after a review in January found the experimental injections provided no protection from the virus that causes AIDS.

    February 3, 2020
    Seattle Times
  • Suth Africa will halt one of the largest and most advanced HIV vaccine trials ever to be undertaken in the country ahead of schedule after the jab was found to be safe but not effective at protecting against HIV infection.

    February 3, 2020
    Bhekisisa
  • The US Government knows how to do smart, effective HIV programming globally — but for the past three years, it has been getting in its own way. That’s because the US President’s Emergency Plan for AIDS Relief (PEPFAR), the largest government commitment to global HIV, was placed at risk when President Trump reintroduced the so-called global gag rule, applying it for the first time to PEPFAR.

    January 23, 2020
    General
    INKSTICK
  • A nightclub at Balaka Town is bulging with sex workers and their clients in search of pleasure and money. Within the compound, faint lights from florescent tubes are casting small beams onto an entrance into an adjoining room.

    January 13, 2020
    The Times Malawi
  • Over the past 30 years, advances ranging from medical technology to policy implementation have reduced new infections and suppressed the virus for those already living with HIV. There is a lot of excitement about technological innovations already on the market and those that will be available in the near future, including preexposure prophylaxis, or PrEP, which could soon be available as implants instead of daily pills. But progress in the global fight against HIV has been uneven, with the San Francisco Bay Area serving as an example of the global inequities in the disease burden.

    January 9, 2020
    Devex
  • Creating HIV prevention strategies that resonate with AGYW requires an understanding of the factors influencing their decision-making and behaviour, particularly with respect to relationship management. The study concluded that messages and interventions perceived to jeopardise or increase friction within sexual relationships are unlikely to resonate or effect behaviour change. In order to optimise the impact of HIV prevention messages and programmes, consideration should be given to the priority that AGYW with high-risk behaviours place on relationship preservation and management

    December 31, 2019
    General
    South African Health Review 2019
  • There is a problem with the decade's greatest medical moments. Most medical advances originate in rich countries, so they are sometimes out of reach for the world's poor — even when they address health problems more common in low-income countries. Treatment for HIV, for example, became available in the U.S. in 1996 but the rollout in Africa didn't begin until 2002. But some breakthroughs of the past decade have gone on to have a truly global impact.

    December 24, 2019
    NPR

Pages